VRNA   $29.94  1.77% Market Open

Verona Pharma PLC
Total Cash 404.60M
totalCashPerShare 0.623
EBITDA -127.97M
Total Debt 122.20M
quickRatio 8.445
currentRatio 8.611
Total Revenue
debtToEquity 72.617
Revenue/Share
ROA -0.21826
ROE -0.56845003
grossProfits
freeCashflow -10.48M
operatingCashflow -53.84M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 19.07B
forwardPE -21.57971
floatShares 387.17M
sharesOutstanding 81.24M
sharesShort 9.01M
sharesShortPriorMonth 8.84M
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.92%
Short Ratio help_outline 8.11%
shortPercentOfFloat 0.12%
impliedSharesOutstanding
bookValue 2.075
Price To Book help_outline 14.35
earningsQuarterlyGrowth
netIncomeToCommon -125.45M
trailingEps -1.60%
forwardEps -1.38%
enterpriseToEbitda -149.02
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.41 3Q 2024
institutionsCount 170
lastUpdated Sept. 16, 2024, 3:14 p.m.